Syndax Pharmaceuticals
SNDX
SNDX
217 hedge funds and large institutions have $953M invested in Syndax Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 86 increasing their positions, 67 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less funds holding
Funds holding: 218 → 217 (-1)
24% less capital invested
Capital invested by funds: $1.26B → $953M (-$302M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
217
Holding in Top 10
7
Calls
$14.4M
Puts
$12.5M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$17.6M | |
| 3 | +$11M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$9.06M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.78M |
Top Sellers
| 1 | -$21.3M | |
| 2 | -$17.6M | |
| 3 | -$16.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.8M |
| 5 |
Morgan Stanley
New York
|
-$13.4M |
